Pivotal Therapeutics Inc. is a specialized pharmaceutical firm primarily dedicated to addressing cardiovascular ailments and promoting general well-being. The company's flagship offering, VASCAZEN, is a medical food available by prescription only. It's specifically designed for the clinical dietary intervention of cardiovascular disease in individuals diagnosed with coronary heart disease who also exhibit low levels of Omega-3 fatty acids, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), in their bloodstream.